Effect of intracoronary adenosine in patients with acute myocardial infarctio
Phase 2
Recruiting
- Conditions
- Acute myocardial infarction.Acute myocardial infarction
- Registration Number
- IRCT20190112042329N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 126
Inclusion Criteria
Age higher than 20 years
An elapse of 12 hours form the primary diagnosis
Exclusion Criteria
Having chronic obstructive pulmonary disease, asthma, less than 90 mm Hg systolic blood pressure, cardiac arrhythmia, sick sinus syndrome and neuropathy
Candidates for coronary artery bypass grafts
Using other medicines, such as verapamil
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiovascular events (i.e., mortality, second myocardial infarction, and stroke during admission). Timepoint: Before and 24 hours after the intervention. Method of measurement: Echocardiography.;Ejection fraction of ventricular. Timepoint: Before and 24 hours after the intervention. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method The reduction of ST-segment. Timepoint: Before and 24 hours after the intervention. Method of measurement: Electrocardiogram (ECG).;Thrombolysis in myocardial infarction flow. Timepoint: Before and 24 hours after the intervention. Method of measurement: TIMI flow grading.